Accredited Investors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $300K | Sell |
12,474
-3,865
| -24% | -$101K | 0.01% | 243 |
|
|
2026
Q1 | $459K | Sell |
16,339
-2,357
| -13% | -$62.8K | 0.02% | 166 |
|
|
2025
Q4 | $466K | Sell |
18,696
-415
| -2% | -$10.5K | 0.02% | 163 |
|
|
2025
Q3 | $487K | Sell |
19,111
-1,334
| -7% | -$32.9K | 0.03% | 150 |
|
|
2025
Q2 | $496K | Buy |
20,445
+747
| +4% | +$17.4K | 0.03% | 136 |
|
|
2025
Q1 | $499K | Buy |
19,698
+605
| +3% | +$15.8K | 0.03% | 128 |
|
|
2024
Q4 | $507K | Sell |
19,093
-1,086
| -5% | -$29.5K | 0.03% | 128 |
|
|
2024
Q3 | $584K | Buy |
20,179
+149
| +0.7% | +$4.35K | 0.03% | 123 |
|
|
2024
Q2 | $560K | Sell |
20,030
-941
| -4% | -$25.9K | 0.04% | 118 |
|
|
2024
Q1 | $582K | Sell |
20,971
-703
| -3% | -$19.5K | 0.04% | 116 |
|
|
2023
Q4 | $624K | Sell |
21,674
-550
| -2% | -$16.6K | 0.04% | 108 |
|
|
2023
Q3 | $737K | Buy |
22,224
+1,101
| +5% | +$38.9K | 0.06% | 92 |
|
|
2023
Q2 | $775K | Buy |
21,123
+93
| +0.4% | +$3.62K | 0.06% | 89 |
|
|
2023
Q1 | $858K | Buy |
21,030
+84
| +0.4% | +$3.63K | 0.07% | 83 |
|
|
2022
Q4 | $1.07M | Buy |
20,946
+2,066
| +11% | +$99.1K | 0.09% | 72 |
|
|
2022
Q3 | $826K | Buy |
18,880
+556
| +3% | +$27K | 0.1% | 75 |
|
|
2022
Q2 | $961K | Sell |
18,324
-295
| -2% | -$15K | 0.11% | 73 |
|
|
2022
Q1 | $964K | Buy |
18,619
+220
| +1% | +$11.4K | 0.09% | 74 |
|
|
2021
Q4 | $1.09M | Sell |
18,399
-725
| -4% | -$35.9K | 0.1% | 74 |
|
|
2021
Q3 | $823K | Sell |
19,124
-140
| -0.7% | -$6.2K | 0.09% | 79 |
|
|
2021
Q2 | $754K | Buy |
19,264
+407
| +2% | +$15.8K | 0.08% | 82 |
|
|
2021
Q1 | $683K | Buy |
18,857
+86
| +0.5% | +$3.05K | 0.09% | 82 |
|
|
2020
Q4 | $691K | Sell |
18,771
-1,190
| -6% | -$43.6K | 0.12% | 77 |
|
|
2020
Q3 | $695K | Sell |
19,961
-28
| -0.1% | -$982 | 0.15% | 70 |
|
|
2020
Q2 | $620K | Sell |
19,989
-1,510
| -7% | -$51.3K | 0.13% | 74 |
|
|
2020
Q1 | $666K | Sell |
21,499
-226
| -1% | -$7.7K | 0.16% | 62 |
|
|
2019
Q4 | $808K | Sell |
21,725
-3,058
| -12% | -$109K | 0.14% | 66 |
|
|
2019
Q3 | $845K | Sell |
24,783
-3,412
| -12% | -$124K | 0.16% | 61 |
|
|
2019
Q2 | $1.16M | Buy |
28,195
+1,414
| +5% | +$56.1K | 0.23% | 48 |
|
|
2019
Q1 | $1.08M | Sell |
26,781
-497
| -2% | -$19.9K | 0.22% | 48 |
|
|
2018
Q4 | $1.13M | Sell |
27,278
-453
| -2% | -$18.8K | 0.25% | 43 |
|
|
2018
Q3 | $1.16M | Buy |
27,731
+2,497
| +10% | +$96.1K | 0.29% | 33 |
|
|
2018
Q2 | $869K | Sell |
25,234
-679
| -3% | -$23.2K | 0.22% | 38 |
|
|
2018
Q1 | $873K | Sell |
25,913
-12,563
| -33% | -$432K | 0.24% | 37 |
|
|
2017
Q4 | $1.32M | Buy |
38,476
+420
| +1% | +$14.3K | 0.37% | 27 |
|
|
2017
Q3 | $1.29M | Buy |
38,056
+14,090
| +59% | +$453K | 0.36% | 30 |
|
|
2017
Q2 | $764K | Sell |
23,966
-7
| -0% | -$221 | 0.2% | 36 |
|
|
2017
Q1 | $778K | Sell |
23,973
-341
| -1% | -$10.8K | 0.19% | 38 |
|
|
2016
Q4 | $749K | Buy |
24,314
+1,030
| +4% | +$31.4K | 0.19% | 35 |
|
|
2016
Q3 | $748K | Buy |
23,284
+393
| +2% | +$13.1K | 0.21% | 36 |
|
|
2016
Q2 | $749K | Sell |
22,891
-2,094
| -8% | -$66.8K | 0.21% | 35 |
|
|
2016
Q1 | $703K | Sell |
24,985
-24
| -0.1% | -$686 | 0.18% | 37 |
|
|
2015
Q4 | $766K | Buy |
25,009
+5,818
| +30% | +$183K | 0.19% | 35 |
|
|
2015
Q3 | $572K | Buy |
19,191
+4,297
| +29% | +$138K | 0.15% | 41 |
|
|
2015
Q2 | $474K | Sell |
14,894
-3
| -0% | -$98 | 0.12% | 42 |
|
|
2015
Q1 | $492K | Buy |
14,897
+35
| +0.2% | +$1.11K | 0.13% | 42 |
|
|
2014
Q4 | $440K | Sell |
14,862
-384
| -3% | -$11K | 0.13% | 44 |
|
|
2014
Q3 | $428K | Sell |
15,246
-1,479
| -9% | -$41.5K | 0.13% | 42 |
|
|
2014
Q2 | $471K | Buy |
16,725
+2,970
| +22% | +$84.7K | 0.15% | 37 |
|
|
2014
Q1 | $420K | Sell |
13,755
-561
| -4% | -$16.7K | 0.14% | 37 |
|
|
2013
Q4 | $417K | Buy |
14,316
+904
| +7% | +$26.3K | 0.15% | 35 |
|
|
2013
Q3 | $366K | Buy |
13,412
+47
| +0.4% | +$1.28K | 0.14% | 38 |
|
|
2013
Q2 | $356K | Buy |
+13,365
| New | +$369K | 0.14% | 38 |
|
Other funds holding PFE
Accredited Investors's PFE Position: Q2 2026 in Review
Accredited Investors reduced its Pfizer (PFE) stake by 24% in Q2 2026, selling an estimated $101K and leaving 12,474 shares worth $300K. The position accounts for 0.01% of the portfolio, ranked #243.
Accredited Investors first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.32M in Q4 2017. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Accredited Investors held 12,474 shares of Pfizer worth $300K as of Q2 2026.
- Accredited Investors sold 3,865 Pfizer shares in Q2 2026, an estimated $101K.
- Pfizer made up 0.01% of Accredited Investors's portfolio in Q2 2026, its #243 holding.
- Accredited Investors first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Accredited Investors's Pfizer position peaked at $1.32M in Q4 2017.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Accredited Investors's 13F filing for Q2 2026, filed 21 Jul 2026.